The CIMAvax vaccine trial is for people with stage IIIB or IV non-small cell lung cancer (NSCLC) who have been treated previously by one line of chemotherapy.
To find out if you may qualify for the study, click "begin."
Unfortunately you are not eligible for this study based on your answer to this question. If you selected incorrectly, you may change your answer; however, a clinician will validate these answers before you can enroll in any study. If you’d like information on other clinical trials for NSCLC, please visit the links below.